1-(furan-2-yl)-3-hydroxy-4,4-dimethylpent-2-en-1-one, 98%, 100mg

2-(3-(pyridin-4-yl)-1H-pyrazol-1-yl)acetonitrile, 95.0%, 250mg

1,2,4-Trimethylcyclohexane (mixture of stereoisomers)>96.0%(GC)500mL

4-Methoxy-3-methylbenzyl chloride (stabilised with calcium carbonate), 98.0%, 250mg

4-(tert-Butyl)-N-(4-(tert-butyl)phenyl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)aniline, 98%, 5g

(R)-(-)-Pyrrolidine-3-carboxylic acid, 95.0%, 1g

(S)-(+)-Phenylsuccinic Acid>98.0%(T)(HPLC)1g

1,3-Dimethyl-1h-indole-2-carbaldehyde, 95%, 2.5g

2-methylthieno[3',2':5,6]benzo[1,2-d]thiazol-5-ol, 95.0%, 250mg

5,5'-Dimethyl-2,2'-bipyridine, 95.0%, 100g

tert-Butyl 4-(3-chloropyrazin-2-yl)piperazine-1-carboxylate, 95.0%, 1g

1-Fluoro-5-methyl-4-(methylsulfonyl)-2-nitrobenzene, 95.0%, 5g

pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidin-6(7H)-one, 95.0%, 5g